Search Results for "Dabur Sanat Pharma"

01:03 EDT 27th October 2016 | BioPortfolio

Matching Channels

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...


Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...


OxyContin, an narcotic <!--LGfEGNT2Lhm-->analgesic produced by Purdue Pharma LP, nets $3m in <!--LGfEGNT2Lhm-->sales annually, placing it 8th in the world for annual sales. OxyContin i...


Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Zyme Communications

Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value, and generate interest from commercial leads...

Matching News

HealthCare at Home India to invest Rs. 100 cr for pan─India expansion, team strength to upto 1,000

HealthCare at Home (HCH) India, a joint venture between the Burman family, the promoters of Dabur Group and founders of Health Care At Home, UK is slating a Rs. 100 crore investment for its pan─Indi...

Fosun’s Yao Pharma invests big in global reach, by Wang Fangqing

As a major member of Fosun Pharma family, Chongqing-based Yao Pharma is a key part of Fosun Pharma’s…


Verona Pharma plc ("Verona Pharma" or the "Company") Confirmation of General Meeting Date 1 July 2016, Cardiff - Verona Pharma plc (AIM: VRP), the drug development company focused on first-in-clas...

Sun Pharma inks distribution pact with Japanese firm Mitsubishi pharma

Biospectrum Sun Pharma announces distribution alliance with Mitsubishi Tanabe Pharma Corporation in Japan [Read more]

Kiadis Pharma Appoints PCT as its Contract Manufacturing Organization in the United States

~ PCT will supply study medication for the US part of Kiadis Pharma's Phase III clinical trial with ATIR101™ ~ Regulatory News: Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amst.....

Sun Pharma gains license to SPARC's epilepsy drug

Sun Pharma and its subsidiary Sun Pharma Advanced Research Co.  -More- 

SPARC licenses Elepsia XR to Sun Pharma

Sun Pharma Advanced Research Company and India’s largest drugmaker Sun Pharma have entered into a licensing…

Big Pharma Sues Big Pharma in Biosimilar Cases

With the number of pharma lawsuits growing quickly, lawyers say the legal landscape has recently gotten a lot more complex

Matching PubMed Articles

Digital health revolution: Perfect storm or perfect opportunity for pharmaceutical R&D?

The convergence of technology and medicine has pushed healthcare to the brink of a major disruption that pharma has, until recently, been slow to recognize. Tech players have pioneered the emerging fi...

A Review of "Big Pharma, Women, and the Labour of Love"by Thea Cacchioni. Toronto, Canada: University of Toronto Press, 2015, 167 pages, $50.00 (hardcover), $21.95 (paperback), $20.85 (Kindle).

Cognitive disorders in stroke patients: the possibilities of pharma-cological correction.

To determine the efficacy and safety of cellex in treatment of cognitive disorders in acute ischemic stroke (IS).

Assessment of the Combined Efficacy of Needling and the Use of Silicone Gel in the Treatment of C-Section and Other Surgical Hypertrophic Scars and Keloids.

To evaluate the individual effectiveness of needling therapy using the Dermapen (Dermapen, Salt Lake City, Utah) and topical therapy with silicone gel (Kelo-cote, Sinclair Pharma, London, England), an...

A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction.

U.S. Food and Drug Administration-approved formulations of botulinum toxin include onabotulinumtoxinA (Botox; Allergan, Inc., Irvine, Calif.), abobotulinumtoxinA (Dysport; Galderma Pharma S.A., Lausan...

Search Whole site using Google

Quick Search
Advertisement Advertisement